• Gemini Bio Launches Moxi V contractpharma
    July 22, 2020
    ​Gemini Bioproducts LLC, a supplier of cell culture solutions and a portfolio company of BelHealth Investment Partners, has launched the Moxi V for precision cell analysis.
PharmaSources Customer Service